Stock-based compensation increased 46.6%
Stock-based compensation changed +46.6% from the comparable as-filed period.
$1.2M→$1.8M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SPOK financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital / assets moved 153 bp higher
Working capital / assets changed +153 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
4.97%→6.51%4 prior comparisons
Total assets decreased 5.4%
Total assets changed -5.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$209.7M→$198.3M4 prior comparisons
Capital expenditure increased 32.5%
Capital expenditure changed +32.5% from the comparable as-filed period.
$557,000→$738,0002 prior comparisons
Current ratio increased 6.5%
Current ratio changed +6.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
1.21→1.294 prior comparisons
Free-cash-flow margin moved 1473 bp higher
Free-cash-flow margin changed +1473 basis points from the comparable as-filed period.
22.38%→37.10%2 prior comparisons
Receivables / revenue moved 2271 bp lower
Receivables / revenue changed -2271 basis points from the comparable as-filed period.
75.86%→53.15%2 prior comparisons
Operating cash-flow margin moved 1532 bp higher
Operating cash-flow margin changed +1532 basis points from the comparable as-filed period.
24.02%→39.34%2 prior comparisons
SBC / revenue moved 186 bp higher
SBC / revenue changed +186 basis points from the comparable as-filed period.
3.69%→5.54%2 prior comparisons
Revenue decreased 2.6%
Revenue changed -2.6% from the comparable as-filed period.
$33.9M→$33.0M2 prior comparisons
Cost of revenue decreased 8.8%
Cost of revenue changed -8.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$7.4M→$6.7M2 prior comparisons
Capex / revenue moved 59 bp higher
Capex / revenue changed +59 basis points from the comparable as-filed period.
1.64%→2.24%2 prior comparisons
Research & development increased 7.9%
Research & development changed +7.9% from the comparable as-filed period.
$3.0M→$3.2M2 prior comparisons
Current assets decreased 3.9%
Current assets changed -3.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$59.5M→$57.2M4 prior comparisons
R&D / revenue moved 94 bp higher
R&D / revenue changed +94 basis points from the comparable as-filed period.
8.84%→9.78%2 prior comparisons
Cash & equivalents decreased 18.0%
Cash & equivalents changed -18.0% from the comparable as-filed period.
$20.2M→$16.6M3 prior comparisons
Working capital / assets moved 307 bp lower
Working capital / assets changed -307 basis points from the comparable as-filed period.
5.29%→2.21%3 prior comparisons
Shares outstanding increased 1.6%
Shares outstanding changed +1.6% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes.
20,590,924→20,918,1377 prior comparisons
Current assets decreased 10.3%
Current assets changed -10.3% from the comparable as-filed period.
$56.5M→$50.6M3 prior comparisons
Total assets decreased 6.3%
Total assets changed -6.3% from the comparable as-filed period.
$208.7M→$195.6M3 prior comparisons
Current ratio decreased 12.0%
Current ratio changed -12.0% from the comparable as-filed period.
1.24→1.093 prior comparisons
Trade receivables decreased 9.0%
Trade receivables changed -9.0% from the comparable as-filed period.
$25.8M→$23.5M3 prior comparisons
Current liabilities increased 1.9%
Current liabilities changed +1.9% from the comparable as-filed period.
$45.4M→$46.3M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.